BiotechTube
Home/Pipeline/AUR112

AUR112

Not specified (Oncology)

Phase 1Active (Initial data reported Dec 2025)

Key Facts

Indication
Not specified (Oncology)
Phase
Phase 1
Status
Active (Initial data reported Dec 2025)
Company
Aurigene Oncology

About Aurigene Oncology

An Indian clinical-stage biotech company developing innovative small molecule cancer therapies through proprietary discovery and strategic global partnerships.

View full company profile

Therapeutic Areas

OncologyImmunology

Other Not specified (Oncology) Drugs

DrugCompanyPhase
IMGS-203ImmunoGenesisPre-clinical
XNW28012Evopoint BiosciencesPhase 3
Anti-TM4SF4 AntibodyAlgok BioPreclinical
Oncology 1Actipulse NeurosciencePre-clinical
SynKIR™-310Verismo TherapeuticsPhase 1
B7H3 Antibody-Drug ConjugateEllipses PharmaClinical
BC3448BioCity BiopharmaPhase 1
BC2027BioCity BiopharmaPhase 1